BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 31387684)

  • 1. Hypoxic Radiosensitizer-Lipid Coated Gold Nanoparticles Enhance the Effects of Radiation Therapy on Tumor Growth.
    Zhao Z; Xu H; Li S; Han Y; Jia J; Han Z; Zhang D; Zhang L; Yu R; Liu H
    J Biomed Nanotechnol; 2019 Sep; 15(9):1982-1993. PubMed ID: 31387684
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypoxia-responsive lipid-poly-(hypoxic radiosensitized polyprodrug) nanoparticles for glioma chemo- and radiotherapy.
    Hua L; Wang Z; Zhao L; Mao H; Wang G; Zhang K; Liu X; Wu D; Zheng Y; Lu J; Yu R; Liu H
    Theranostics; 2018; 8(18):5088-5105. PubMed ID: 30429888
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gold nanoparticles and electroporation impose both separate and synergistic radiosensitizing effects in HT-29 tumor cells: an in vitro study.
    Rezaee Z; Yadollahpour A; Bayati V; Negad Dehbashi F
    Int J Nanomedicine; 2017; 12():1431-1439. PubMed ID: 28260889
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Investigation of different targeting decorations effect on the radiosensitizing efficacy of albumin-stabilized gold nanoparticles for breast cancer radiation therapy.
    Kefayat A; Ghahremani F; Motaghi H; Mehrgardi MA
    Eur J Pharm Sci; 2019 Mar; 130():225-233. PubMed ID: 30711685
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Albumin-Modified Gold Nanoparticles as Novel Radiosensitizers for Enhancing Lung Cancer Radiotherapy.
    Chen Y; Liu S; Liao Y; Yang H; Chen Z; Hu Y; Fu S; Wu J
    Int J Nanomedicine; 2023; 18():1949-1964. PubMed ID: 37070100
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhancing the effect of 4MeV electron beam using gold nanoparticles in breast cancer cells.
    Mehrnia SS; Hashemi B; Mowla SJ; Arbabi A
    Phys Med; 2017 Mar; 35():18-24. PubMed ID: 28285936
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ultrathin gold nanowires to enhance radiation therapy.
    Bai L; Jiang F; Wang R; Lee C; Wang H; Zhang W; Jiang W; Li D; Ji B; Li Z; Gao S; Xie J; Ma Q
    J Nanobiotechnology; 2020 Sep; 18(1):131. PubMed ID: 32917209
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radiosensitization effect of folate-conjugated gold nanoparticles on HeLa cancer cells under orthovoltage superficial radiotherapy techniques.
    Khoshgard K; Hashemi B; Arbabi A; Rasaee MJ; Soleimani M
    Phys Med Biol; 2014 May; 59(9):2249-63. PubMed ID: 24733041
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypoxia-Responsive Aggregation of Gold Nanoparticles for Near-Infrared-II Photoacoustic Imaging-Guided Enhanced Radiotherapy.
    Geng H; Chen K; Cao L; Liu L; Huang Y; Liu J
    Langmuir; 2023 Mar; 39(11):4037-4048. PubMed ID: 36907993
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhancement of radiotherapy efficacy by silver nanoparticles in hypoxic glioma cells.
    Liu Z; Tan H; Zhang X; Chen F; Zhou Z; Hu X; Chang S; Liu P; Zhang H
    Artif Cells Nanomed Biotechnol; 2018; 46(sup3):S922-S930. PubMed ID: 30307330
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gold nanoparticles enhance anti-tumor effect of radiotherapy to hypoxic tumor.
    Kim MS; Lee EJ; Kim JW; Chung US; Koh WG; Keum KC; Koom WS
    Radiat Oncol J; 2016 Sep; 34(3):230-238. PubMed ID: 27730800
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of a hypoxia-triggered and hypoxic radiosensitized liposome as a doxorubicin carrier to promote synergetic chemo-/radio-therapy for glioma.
    Liu H; Xie Y; Zhang Y; Cai Y; Li B; Mao H; Liu Y; Lu J; Zhang L; Yu R
    Biomaterials; 2017 Mar; 121():130-143. PubMed ID: 28088075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multifunctional Chitosan-Capped Gold Nanoparticles for enhanced cancer chemo-radiotherapy: An invitro study.
    Fathy MM; Mohamed FS; Elbialy N; Elshemey WM
    Phys Med; 2018 Apr; 48():76-83. PubMed ID: 29728233
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictive modeling of hypoxic head and neck cancers during fractionated radiotherapy with gold nanoparticle radiosensitization.
    Huynh M; Kempson I; Bezak E; Phillips W
    Med Phys; 2021 Jun; 48(6):3120-3133. PubMed ID: 33818799
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Self-assembled angiopep-2 modified lipid-poly (hypoxic radiosensitized polyprodrug) nanoparticles delivery TMZ for glioma synergistic TMZ and RT therapy.
    Zong Z; Hua L; Wang Z; Xu H; Ye C; Pan B; Zhao Z; Zhang L; Lu J; Mei LH; Rutong Y
    Drug Deliv; 2019 Dec; 26(1):34-44. PubMed ID: 30744436
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Promising, Novel Radiosensitizer Nanodrug Complex for Oral Cavity Cancer: Cetuximab and Cisplatin-Conjugated Gold Nanoparticles.
    Sürer Şİ; Elçitepe TB; Akçay D; Daşkın E; Çalıbaşı Kocal G; Arıcan Alıcıkuş Z; Eskiizmir G; Yapıcı K; Başbınar Y
    Balkan Med J; 2021 Sep; 38(5):278-286. PubMed ID: 34462254
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Size-dependent radiosensitization of PEG-coated gold nanoparticles for cancer radiation therapy.
    Zhang XD; Wu D; Shen X; Chen J; Sun YM; Liu PX; Liang XJ
    Biomaterials; 2012 Sep; 33(27):6408-19. PubMed ID: 22681980
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cisplatin-conjugated gold nanoparticles as a theranostic agent for head and neck cancer.
    Davidi ES; Dreifuss T; Motiei M; Shai E; Bragilovski D; Lubimov L; Kindler MJJ; Popovtzer A; Don J; Popovtzer R
    Head Neck; 2018 Jan; 40(1):70-78. PubMed ID: 29130566
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Critical parameters to translate gold nanoparticles as radiosensitizing agents into the clinic.
    Moloudi K; Khani A; Najafi M; Azmoonfar R; Azizi M; Nekounam H; Sobhani M; Laurent S; Samadian H
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2023; 15(6):e1886. PubMed ID: 36987630
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gold nanoparticles, radiations and the immune system: Current insights into the physical mechanisms and the biological interactions of this new alliance towards cancer therapy.
    Dimitriou NM; Tsekenis G; Balanikas EC; Pavlopoulou A; Mitsiogianni M; Mantso T; Pashos G; Boudouvis AG; Lykakis IN; Tsigaridas G; Panayiotidis MI; Yannopapas V; Georgakilas AG
    Pharmacol Ther; 2017 Oct; 178():1-17. PubMed ID: 28322970
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.